Diseases and Drugs


fdadecision april28 25jun20 The first half of 2020 looks set to end on an encouraging note for new drug approvals despite the ongoing coronavirus pandemic. Let's take a look at the biotech stocks facing FDA decision in July.

astrazeneca june12 When will a safe and effective vaccine for COVID-19 be ready? Vaccine makers are racing against time to develop a vaccine to fight the novel coronavirus. There are more than 130 candidate vaccines in development against SARS-COV-2, the pathogen that causes COVID-19, of which 10 have moved into clinical trials.

solenopws june09 Although there are FDA approved therapies for the treatment of growth failure in children with PWS, say, Pfizer's (PFE) recombinant human growth hormone Genotropin (somatropin) and Sandoz/Novartis' Omnitrope, a biosimilar for Genotropin, there is no approved therapy yet to treat hyperphagia or excessive eating, the cardinal symptom of PWS.

fda1 may22 The FDA has been focusing mainly on COVID-19-related review since March. But that said, the regulatory decision on drugs proposed for rare tumors and life-threatening diseases has not been deferred. Now, let's take a look at the biotech stocks awaiting a regulatory decision in the month of June.

lab april30 The ongoing COVID-19 pandemic has sickened over 3.25 million people and has killed 233,014 people, according to data from Johns Hopkins University.

fda2 042420 So far this year, 16 novel drugs have received FDA approval compared to 9 which were greenlighted during the same period last year. Now, let's take a look at the biotech stocks that are awaiting a regulatory decision in May 2020.

pfizer april09 Drinking too much alcohol can lead to the accumulation of fat in the liver, which in turn can lead to irreversible damage to the organ over the long run. But people who don't drink or drink very little also can develop a liver disease, which goes by the name non-alcoholic fatty liver disease, or NAFLD, a condition caused by the buildup of extra fat in liver cells.

pharma oct17 The novel coronavirus that originated in the city of Wuhan in China last December, has spread to almost all the countries, affecting millions. As of this writing, the number of confirmed cases is 1,274,346 and the death toll is 69,480.

covid april03 Currently, there are no treatments or vaccines for COVID-19. A number of companies are racing to find a treatment or vaccine for the same. What is the latest by which a vaccine for COVID-19 will be available?

coronavirusvaccine march23 While the governments, researchers, companies among others are in search of one or more treatments that can help address the deadly Coronavirus, investors are in search of investment opportunities in biotech and pharmaceutical stocks. The following are some of the companies developing drugs/vaccines for COVID-19.

Diagnostics play a key role in combating a flu pandemic because the test results not only help to know if a person has been infected by the virus but will also help to take measures to prevent the infection spread.

pharma 051117 17mar20 Diagnostics play a key role in combating a flu pandemic because the test results will help to know if a person has been infected by the virus and will also help to take measures to prevent the spread of infections.

disney march16 The World Health Organization, on March 11, 2020, declared COVID-19, caused by SARS-CoV-2 virus, a pandemic due to the alarming levels of spread and severity of the virus.

fda mar02 A medical hot topic that been making headlines this year is the coronavirus outbreak. As per the latest World Health Organization report, 53 countries have been impacted by the new coronavirus COVID-19, with 85,403 confirmed cases globally - a vast majority of them being in China. The number of deaths due to the coronavirus is 2,838 in China and 86 outside of China.

corona feb27 The new coronavirus, COVID-19, which originated in China, has now spread to least 47 countries, infecting over 81,000 people and killing 3,000 people, with the majority of them in China.

Follow RTT